Oxford BioLabs Deutschland GmbH

Business Strategies

Oxford BioLabs GmbH is a science-based company which develops novel, effective health and beauty therapies to help people stay young and healthy longer and to extend their quality of life. Our fields of research are: Androgenetic Alopecia (AGA), Hair Pigmentation, and Rejuvenation.

Core Technologies and Services

Oxford BioLabs develops and distributes novel food supplements (TRX2) for the treatment of androgenetic alopecia (AGA), which is commonly known as male and female pattern baldness. Currently available therapies include drugs or hair transplant surgery, which treat acute symptoms but have side effects, could lead to hospitalization or show an unsatisfactory patient outcome. For the time being there is no cure against AGA and new treatment options are urgently needed. Our ultimate goal is to develop a cure for hair loss and thereby set a new standard for the treatment of AGA.

Patent, Licenses, Co-operations

• Co-operation with the University of Oxford, UK
• License-Agreement with Lonza Ltd., Switzerland
• Patent-pending